| Literature DB >> 33672223 |
Simon Grootendorst1, Jonathan de Wilde1, Birgit van Dooijeweert1, Annelies van Vuren2, Wouter van Solinge1, Roger Schutgens2, Richard van Wijk1, Marije Bartels2.
Abstract
Rare hereditary anemias (RHA) represent a group of disorders characterized by either impaired production of erythrocytes or decreased survival (i.e., hemolysis). In RHA, the regulation of iron metabolism and erythropoiesis is often disturbed, leading to iron overload or worsening of chronic anemia due to unavailability of iron for erythropoiesis. Whereas iron overload generally is a well-recognized complication in patients requiring regular blood transfusions, it is also a significant problem in a large proportion of patients with RHA that are not transfusion dependent. This indicates that RHA share disease-specific defects in erythroid development that are linked to intrinsic defects in iron metabolism. In this review, we discuss the key regulators involved in the interplay between iron and erythropoiesis and their importance in the spectrum of RHA.Entities:
Keywords: erythropoiesis; ineffective erythropoiesis; iron metabolism; iron overload
Mesh:
Substances:
Year: 2021 PMID: 33672223 PMCID: PMC7927117 DOI: 10.3390/ijms22042204
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923